News

A new microchip invented by Scripps Research scientists can reveal how a person's antibodies interact with viruses-using just a drop of blood.
A new microchip invented by Scripps Research scientists can reveal how a person's antibodies interact with viruses-using just ...
Centre for Cellular and Molecular Platforms Thursday launched a ‘One Health AMR Challenge 2025’ in Bengaluru to support ...
Single B-cell technologies have emerged as powerful screening tools to accelerate antibody discovery, offering R&D teams the potential to interrogate millions of individual antibody-secreting ...
A man spent 18 years injecting himself with venom, almost dying more than once – and now his blood is behind a new snakebite treatment.
Many patent applicants currently face difficulty in obtaining antibody claims because of written description and enablement rejections under 35 U.S.C. §112(a). The USPTO routinely rejects claims ...
Bispecific antibodies (bsAbs) have emerged as a novel class of therapeutics, offering a dual-targeting strategy to enhance the therapeutic efficacy of monoclonal antibodies, which is often limited by ...
Bispecific antibodies target specific cells, offering effective treatment for relapsed/refractory multiple myeloma, with varying side effect profiles.
Researchers identify key antibodies that bring us one step closer to treatment and vaccine for norovirus, a prevalent and difficult virus to prevent.
Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.
Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...